Prestige Brands (PBH) Tops Q3 EPS by 4c, Revenues Beat; Raises FY21 EPS/Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Prestige Consumer Healthcare Inc. Reports Fiscal 2021 Third Quarter Results
February 4, 2021 6:00 AM ESTRevenue was $238.8 Million in Third Quarter Fiscal 2021Diluted EPS of $0.81 in Third Quarter Fiscal 2021Net Cash Provided by Operating Activities for First Nine Months of Fiscal 2021 Increased 10% to $176.5 millionRaising Full-Year Fiscal 2021 Outlook for Revenue and Earnings Per Share
TARRYTOWN, N.Y., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) today reported financial results for its third quarter and first nine months ended December 31, 2020.
Our third quarter and year-to-date performance continues to reflect the many benefits of our leading and diverse portfolio of brands and our... More
